Pipeline Progress

Both Arcellx and BlueRock Therapeutics have robust pipelines that focus on various therapeutic areas. In this segment of Cell & Gene Live, Driving Down COGS: Automation’s Role in Cell Therapy Manufacturing featuring BlueRock’s CTO Craig Beasley and Arcellx’s CTO, Narinder Singh, explain how process automation looks different per therapeutic focus area.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene

Thermo Fisher Scientific Bioproduction